ONCOLOGY / RESEARCH LETTER
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Atrophic gastritis and intestinal metaplasia are precursor lesions of gastric cancer. The aim of this study was to determine the usefulness of the biomarkers pepsinogen I(PgI), pepsinogen II (PgII), gastrin-17, and H. pylori antibodies in the identification of precursor lesions.

Methods:
We studied 129 patients with gastric symptoms. The biomarker status was determined using GastroPanel by means of the ELISA-technique.

Results:
Biomarkers detected atrophy in 14% of the subjects, and 49.6% had positive antibodies for H. pylori. A PgI/PgII ratio < 3 was an important risk biomarker for precursor lesions in our population (OR = 9.171, 95% CI: 1.723–48.799, p = 0.009); however, biomarkers showed low accuracy with histopathological study.

Conclusions:
In the Western Mexican population, precursor lesions (AG, IM) are common in adults (45%) with dyspepsia but infrequent in children (8%). H. pylori infection was detected in 41.3% of adults and 16.0% of children. Of the studied biomarkers, a PgI/PgII ratio < 3 was an important risk factor for precursor lesions such as AG or IM in our population, with an OR of 9.171 (95% CI: 1.723–48.799, p = 0.009).

 
REFERENCES (13)
1.
Ricuarte O, Gutierrez O, Cardona H, Kim JG, Graham DY, El-Zimaity HM. Atrophic gastritis in young children and adolescents. J Clin Pathol 2005; 58: 1189-93.
 
2.
Nares-Cisneros J, Jaramillo-Rodríguez Y, Martínez-Ordaz VA, et al. Immunochromatographic monoclonal test for detection of Helicobacter pylori antigen in stool is useful in children from high-prevalence developing country. Helicobacter 2007; 12: 354-8.
 
3.
Guarner J, Mohar A, Parsonnet J, Halperin D. The association of Helicobacter pylori with gastric cancer and preneoplastic gastric lesions in Chiapas, Mexico. Cancer 1993; 71: 297-301.
 
4.
White JR, Banks M. Identifying the pre-malignant stomach: from guidelines to practice. Transl Gastroenterol Hepatol 2022; 7: 8.
 
5.
Pogoriler J, Kamin D, Goldsmith JD. Pediatric non-Helicobacter pylori atrophic gastritis: a case series. Am J Surg Pathol 2015; 39: 786-92.
 
6.
Peleteiro B, Bastos A, Ferro A, Lunet N. Prevalence of Helicobacter pylori infection worldwide: a systematic review of studies with national coverage. Dig Dis Sci 2014; 59: 1698-709.
 
7.
Agin M, Batun I, Ozdemir S, Doran F, Tumgor G. Prevalence of Helicobacter pylori in Turkish children with celiac disease and its effect on clinical, histopathological, and laboratory parameters. Arch Med Sci 2019; 15: 1475-81.
 
8.
Chacaltana-Mendoza A, Soriano-Álvarez C, Frisancho-Velarde O. Factores de riesgo asociados a metaplasia intestinal gástrica en pacientes sin enfermedad gastroduodenal significativa. Está siempre asociada la infección por Helicobacter pylori? [Associated risk factors in patients with gastric intestinal metaplasia with mild gastroduodenal disease. Is it always related to Helicobacter pylori infection?]. Rev Gastroenterol Peru 2012; 32: 50-7.
 
9.
Kitahara F, Kobayashi K, Sato T, Kojima Y, Araki T, Fujino MA. Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut 1999; 44: 693-7.
 
10.
Mattar R, Marques SB, Ribeiro IB, Visconti TAC, Funari M, DE Moura EGH. Diagnostic accuracy of GASTROPANEL® for atrophic gastritis in brazilian subjects and the effect of proton pump inhibitors. Arq Gastroenterol 2020; 57: 154-60.
 
11.
Coelho M, Ribeiro HG, Gomes C, Marinho FP, Barbosa AJA, Coelho LGV. Helicobacter pylori chronic gastritis on patients with premalignant conditions: OLGA and OLGIM evaluation and serum biomarkers performance. Arq Gastroenterol 2021; 58: 39-47.
 
12.
Grad C, Pop A, Gaborean E, Grad S, Dumitrascu D. Value of GastroPanel in the diagnosis of atrophic gastritis Exp Ther Med 2021; 22: 1347.
 
13.
Gašenko E, Bogdanova I, Sjomina O, et al. Assessing the utility of pepsinogens and gastrin-17 in gastric cancer detection. Eur J Cancer Prev 2023; 32: 478-84.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top